Signal
What human evidence tends to support
Moderate-to-strong for triglycerides; guideline discussions for ASCVD risk; mixed for mood and cognition.
Context
Where claims often outrun the trials
High evergreen marketing; evidence is real but narrower than “cure-all” framing.
Retail framing
What products usually promise
Inflammation and cognition marketing is broad; benefits depend on baseline intake, dose, and outcome measured.
Our verdict label
Evidence is real but uneven: useful context exists; certainty is lower than marketing often implies.
Same ingredient, other questions
Focused pages for common searches about Omega-3 fatty acids. Each uses the same underlying evidence file with a different lens.
Explore further
A few hand-picked entry points around Omega-3 fatty acids: categories, answers to narrow questions, and comparisons.
Related ingredients
Ingredients we group near Omega-3 fatty acids in our model - not interchangeable, but often read together.
- Alpha-lipoic acid (ALA)64/100Mixed evidence
Antioxidant used in research for diabetic neuropathy in some clinical contexts; OTC ‘metabolic optimizer’ claims are broader than proof.
- Curcumin66/100Mixed evidence
Bioactive curcuminoids have anti-inflammatory lab appeal; human absorption issues and mixed clinical outcomes limit certainty.
- Coenzyme Q10 (CoQ10)66/100Mixed evidence
Mitochondrial electron carrier; evidence clusters around statin-associated muscle symptoms contexts and some heart failure discussions - not a universal energy hack.
Alternatives
Swaps people discuss alongside Omega-3 fatty acids - still judge each ingredient on its own evidence.